Brind.

Perspective Therapeutics Reports Q3 Loss, Missing Analyst Expectations

1 report, 1 independent Updated Mon 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

On November 9, 2026, Perspective Therapeutics, Inc. reported a third-quarter loss of $32.4 million. The company stated that its per-share loss was 27 cents, while revenue for the period totaled $20,000. These results were below the average estimate of 24 cents per share from surveyed analysts.

From leadertelegram.com

Why it matters

Some supportBrind's analysis of the reports

The company's financial performance missed Wall Street expectations, indicating a shortfall in profitability relative to market forecasts. This directly impacts the company's financial standing and investor sentiment.

From leadertelegram.com

Who's involved

  • SeattleLocation of Perspective Therapeutics, Inc.

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped